Tuberculosis studies handling and reporting of patients with presumed tuberculosis found not to have tuberculosis
Country | Diagnoses | Management | History of tuberculosis | Previous tuberculosis testing | WHO estimated incidence (year of study) | ||
Tuberculosis (per 100 000) | HIV (per 1000) | ||||||
Affolabi et al (2011)32 | Benin | NR | 15 days erythromycin | NR | NR | 71 | 0.69 |
Boehme et al (2011)19 | South Africa | NR | NR | NR | NR | 1260 | 10.29 |
Uganda | NR | NR | NR | NR | 213 | 3.55 | |
Bruchfeld et al (2002)20 | Ethiopia | 8 pneumocystis pneumonia | NR | 66* | NR | NR | 1.79 |
Cuevas et al (2011)24 | Ethiopia | NR | NR | NR | NR | 296 | 0.44 |
Nigeria | NR | NR | NR | NR | 219 | 0.79 | |
Deribew et al (2012)28 | Ethiopia | NR | NR | NR | NR | 282 | 0.41 |
Dorman et al (2018)25 | South Africa (Cape Town) | NR | NR | 59 | NR | 805 | 5.45 |
South Africa (Johanesburg) | NR | NR | 55 | NR | 805 | 5.45 | |
Kenya | NR | NR | 20 | NR | 348 | 1.17 | |
Uganda | NR | NR | 15 | NR | 201 | 1.89 | |
Hamusse et al (2017)29 | Ethiopia | NR | NR | NR | NR | 224 | 0.25 |
Hanrahan et al (2014)26 | South Africa | 9 non-tuberculous mycobacteria | NR | NR | NR | 1200 | 8.67 |
Huerga et al (2012)33 | Kenya | 11 non-tuberculous mycobacteria | 5 days amoxicillin | 92 | NR | 566 | 2.22 |
Jayasooriya et al (2019)6 | The Gambia | 2 malignancy: 2 lung 1 haematological | Clinically indicated | 16* | NR | 162 | 1.07 |
32 other respiratory tract infections | |||||||
8 pneumonia | |||||||
4 asthma | |||||||
2 pleural effusions | |||||||
1 lung abscess | |||||||
10 heart failure | |||||||
2 structural heart disease | |||||||
1 ischaemic heart disease | |||||||
2 chronic renal failure | |||||||
43 unknown | |||||||
Lawson et al (2008)27 | Nigeria | NR | NR | NR | NR | 219 | 0.91 |
Ling et al (2011)18 | South Africa | NR | NR | NR | NR | 1200 | 8.67 |
Merid et al (2019)30 | Ethiopia | NR | NR | 151* | NR | 177 | 0.2 |
Munyati et al (2005)†21 | Zimbabwe | 178 other respiratory tract infections | Clinically indicated | 97 | NR | 607 | 8.67 |
87 bacterial pneumonia | |||||||
34 fibrotic lung disease: 28 post-tuberculous disease 2 idiopathic diffuse fibrosis | |||||||
26 asthma | |||||||
8 pneumocystis pneumonia | |||||||
5 cryptococcosis | |||||||
15 heart failure | |||||||
5 malignancy: 3 Kaposi sarcoma 1 primary bronchus 1 metastatic breast | |||||||
16 unknown | |||||||
Nliwasa et al (2016)22 | Malawi | NR | NR | NR | NR | 261 | 3.2 |
Reither et al (2010)23 | Tanzania | NR | NR | NR | NR | 492 | 2.75 |
Sekandi et al (2014)31 | Uganda | NR | NR | NR | NR | 217 | 3.7 |
Theron et al (2011)17 | South Africa | NR | NR | 158 | NR | 1270 | 11.82 |
*History of tuberculosis in participants without tuberculosis,
†Participants diagnosed with multiple conditions.
NR, not reported.